Product Information
NYSTATIN-TRIAMCINOLONE CREAM is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.2246 per GM under NDC 62332060630. Its NADAC has been published 273 times since Jul 14, 2021.
FDA first approved this application on Mar 31, 2021. Its Orange Book therapeutic-equivalence code is AT.
Strength
100000; 1 [USP'U]/g; mg/g
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332060630
Classification
Generic
Dosage Form
CREAM
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
NYSTATIN; TRIAMCINOLONE ACETONIDEApproval Type
Generic (ANDA)
FDA Application
ANDA214090FDA Approved
3/31/2021
TE Code
AT
On Market Since
4/2/2021
Pharmacological Classes
Price Statistics
The NADAC for NYSTATIN-TRIAMCINOLONE CREAM has been published 273 times since Jul 14, 2021, and over the history we have for it it has declined 53.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2246 per GM |
|---|---|
| All-time high | $0.6614 (Jan 12, 2022) |
| All-time low | $0.2047 (Nov 20, 2024) |
| 52-week high | $0.2667 |
| 52-week low | $0.2127 |
| Median price | $0.3485 |
| Average price | $0.3533 |
| Largest weekly change | +81.7% (Aug 21, 2024) |
| Weeks tracked | 273 |
| Tracking since | Jul 14, 2021 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 15% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Alembic Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Nystatin and Triamcinolone Acetonide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NYSTATIN-TRIAMCINOLONE CREAM?
The current National Average Drug Acquisition Cost (NADAC) for NYSTATIN-TRIAMCINOLONE CREAM, manufactured by Alembic Pharmaceuticals Inc., is $0.2246 per GM (NDC 62332060630), effective Sep 30, 2026.
How has the price of NYSTATIN-TRIAMCINOLONE CREAM changed over time?
Over the history we have for it, the NADAC for NYSTATIN-TRIAMCINOLONE CREAM has declined 53.3%. It has been tracked across 273 weekly CMS publications since Jul 14, 2021.
What are the highest and lowest recorded NADAC prices for NYSTATIN-TRIAMCINOLONE CREAM?
Since Jul 14, 2021, the NADAC for NYSTATIN-TRIAMCINOLONE CREAM has ranged from a low of $0.2047 (Nov 20, 2024) to a high of $0.6614 (Jan 12, 2022), with a median of $0.3485 per GM.
Are there cheaper alternatives to NYSTATIN-TRIAMCINOLONE CREAM?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NYSTATIN-TRIAMCINOLONE CREAM, is $0.1916 per GM — about 15% below NYSTATIN-TRIAMCINOLONE CREAM.
Who manufactures NYSTATIN-TRIAMCINOLONE CREAM?
NYSTATIN-TRIAMCINOLONE CREAM (NDC 62332060630) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.